A Danish research team from the University of Copenhagen has designed a simple technique that makes it possible to quickly and easily develop a new type of vaccines. The simple and effective technique will pave the way for effective vaccines against not only infectious diseases but also cancer and other chronic diseases.
The next generation of vaccines may soon see the light of day, because Danish researchers have discovered a completely new and simple method which sets new standards for the development of vaccines.
“The major research breakthrough is that we have created a general and user-friendly platform for the development of a special type of effective and safe vaccines. The highly effective method opens a new door for controlling diseases such as cancer, asthma, allergies and cardiovascular diseases by means of vaccines. We are therefore already now able to initiate strategies to combat some of the biggest killers in the western world,” says Postdoc Adam Sander, Department of Immunology and Microbiology, University of Copenhagen.
How the new vaccines work
The idea behind the new technique is to mimic the structure of a virus. When you have made the virus structure, it is used as a platform onto which are glued harmless parts of the disease which you want to vaccinate against. This creates an overall virus-like structure, which constitutes an important danger signal for the body. The immune system will therefore produce antibodies against the disease – a mechanism which has been difficult to activate by traditional vaccines. The Danish research team’s technology is also so effective that it can trick the immune system into attacking the body’s own cells, which may be used in the treatment of a number of serious diseases, e.g. cancer, which are not caused by foreign organisms.
“We can see from our experiments that the method works. The method is generic, which means that we can glue, for example, different parts of pathogenic organisms onto the surface of the virus-like platform. Previously, it was a major problem to activate the immune system and get an adequate response. We have lacked the possibility to easily create a vaccine which mimics something that will trigger a natural response from the body, but the new virus-like platform now allows us to do so. In other words, we now have a unique technique that enables us to develop vaccines against diseases that we have so far been unable to fight,” says PhD student Susan Thrane.
The vaccine breakthrough also means that previous research in vaccines can get a new life. For many years, researchers have tried to find vaccines against, for example, malaria, cancer and allergies, but the vaccines have either been too ineffective or dangerous. However, the new research provides the ‘structural’ building blocks that were needed to make the vaccines effective. This means that new vaccine research can proceed directly to the development and testing of new vaccines against, for example, breast cancer and allergies.
Huge potential for development of inexpensive vaccines in low-income countries
The technique for the development of the new type of vaccines is very simple. Where vaccines have so far been complicated to develop and produce, it will now be possible for laboratories all over the world to employ and implement the technique.
“It has always been an important mission for us to make the platform available for researchers all over the world. With our research, we offer a very simple tool that allows health professionals to produce complex vaccines in an effective, safe and cost-effective manner. It will be a game changer for low-income countries, which can now make vaccines targeted at widespread diseases such as tuberculosis and malaria. There is no doubt that the new results will have a significant impact on tomorrow’s vaccines and public health,” says Professor Ali Salanti.
Learn more: Danish researchers behind vaccine breakthrough
The Latest on: Vaccines
via Google News
The Latest on: Vaccines
- McEnany praises Trump for fast-tracking 'landmark' COVID vaccineson October 10, 2020 at 2:27 pm
Breaking tonight, the Trump campaign is tellingFOX News that President Trump does in factplan to participate in the October 15th debatewith Joe Biden. And at this hour, the president is back at the ...
- China finally joined a global effort to distribute coronavirus vaccines equally, while the US is still refusing because the WHO is involvedon October 10, 2020 at 8:23 am
The US refused to join the Covax vaccine initiative in September, with the White House calling the World Health Organization "corrupt." ...
- VBI Vaccines, Inc. (VBIV) Gains But Lags Market: What You Should Knowon October 9, 2020 at 3:45 pm
VBI Vaccines, Inc. (VBIV) closed the most recent trading day at $2.95, moving +0.68% from the previous trading session. This move lagged the S&P 500's daily gain of 0.88%. Elsewhere, the Dow gained 0.
- Wells Fargo has a 'Covid beta' portfolio to play positive news on treatment, vaccineson October 9, 2020 at 3:14 pm
The market appears to be coming around to our bullish views on ‘Covid betas’ (i.e., rallying on positive Covid solutions and news flow), easy 1H21 comps, improving growth, potential vaccines,” the ...
- Whistleblower On How Political Pressure Affects Safety Of Coronavirus Vaccineson October 9, 2020 at 1:08 pm
NPR's Mary Louise Kelly talks with Rick Bright, former Biomedical Advanced Research and Development Authority director, about his whistleblower complaint on political pressure over the coronavirus.
- China Joins Covax Global Initiative to Provide Covid-19 Vaccines to Poor Countrieson October 9, 2020 at 1:08 pm
China will take part in a global effort to distribute Covid-19 vaccines to poorer countries, Beijing said, making it the most prominent nation to join a World Health Organization initiative the U.S.
- China joins global Covax alliance to distribute coronavirus vaccineson October 9, 2020 at 9:14 am
China on Friday said it is joining Covax, an international effort co-led by the World Health Organization (WHO) to distribute a vaccine against the coronavirus.
- China says will purchase COVAX vaccines for 1% of populationon October 9, 2020 at 8:09 am
China will purchase COVID-19 vaccines for 1% of its population, or 15 million people, via a global scheme backed by the World Health Organization, the Foreign Ministry said on Friday.
- China to purchase COVAX vaccines for 1% of population, says foreign ministryon October 9, 2020 at 6:15 am
China will purchase coronavirus vaccines via the global COVAX programme for 1% of its population, the Foreign Ministry said on Friday.
- Distrusting Trump, States Plan to Vet COVID Vaccines Themselves. Bad Idea, Say Expertson October 8, 2020 at 7:09 am
As trust in the Food and Drug Administration wavers, several states have vowed to conduct independent reviews of any COVID-19 vaccine the federal agency authorizes. But top health experts say such ...
via Bing News